siRNA therapy reduces triglycerides in individuals with uncommon health condition

.INVESTIGATION EMPHASIZE.19 September 2024.

Plozasiran decreased triglyceride amounts by 80% and reduced the threat of pancreatitis in patients with chronic chylomicronemia, with or without a hereditary medical diagnosis.